by Salomi LBSP | Jun 3, 2025 | News
Leyden Labs has secured €20 million in financing from the European Investment Bank (EIB), supported by HERA Invest under the EU’s InvestEU programme. The funding will support the clinical development of Leyden Labs’ PanFlu nasal spray, an intranasal antibody therapy...
by Salomi LBSP | Jun 2, 2025 | News
Researchers at Leiden University Medical Center (LUMC), in collaboration with Erasmus MC and the Oncode Institute, have developed a novel vaccine targeting non-small cell lung cancer (NSCLC). This vaccine aims to expose cancer cells that have evaded the immune system,...
by Bilyana LBSP | Jun 1, 2025 | News
The May edition of TechTalk at Leiden Bio Science Park was a reminder that women’s health is not a niche. It’s a vital priority for the future of healthcare. Hosted in collaboration with Rijksmuseum Boerhaave, the session sparked conversations that continue to...
by Salomi LBSP | May 30, 2025 | News
Leiden University Medical Center (LUMC) has achieved a national milestone by treating the first Dutch patient with an autoimmune disease using CAR-T cell therapy. This approach, previously reserved for cancer treatment, was applied to a patient with severe...
by Bilyana LBSP | May 30, 2025 | News
The special edition of Life Sciences Café at Grand Café de Stal brought a unique blend of ideas and vibrant community spirit to Leiden Bio Science Park. Co-hosted with hollandbio, this edition featured three inspiring pitches from startups tackling some of today’s...
by Salomi LBSP | May 28, 2025 | News
TNO and FAST (Financiering en Acceleratie voor Therapieontwikkeling) have launched a strategic collaboration to accelerate the development of advanced therapies, including ATMPs, radiopharmaceuticals, treatments for rare diseases, infectious diseases, and drug...